Page last updated: 2024-10-30

leflunomide and Age-Related Osteoporosis

leflunomide has been researched along with Age-Related Osteoporosis in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Velázquez Benito, A1
Bellosta Diago, E1
Santos Lasaosa, S1
Pascual Millán, LF1

Other Studies

1 other study available for leflunomide and Age-Related Osteoporosis

ArticleYear
[Acute sensory-motor axonal neuropathy (Guillain-Barre syndrome) following vertebroplasty].
    Medicina clinica, 2014, Sep-15, Volume: 143, Issue:6

    Topics: Accidental Falls; Arthritis, Rheumatoid; Female; Guillain-Barre Syndrome; Humans; Immunocompromised

2014